Deleterious de novo SHANK2 mutations have been identified in individuals with intellectual disability (ID), autism spectrum disorders (ASD), developmental delay, and attention deficit and hyperactivity disorder2–5. This evidence concerns the gene SHANK2 and Intellectual disability.